The pulmonary physician in critical care - part 9: non-ventilatory strategies in ARDS.

J Cranshaw, M J D Griffiths, T W Evans

Journal: Thorax 2002;57(9):823-9

PMID: 12200529

Free Full Text on HighWire View on PubMed

Abstract

Pharmacological approaches to the treatment of ARDS are reviewed. Future treatments should be targeted at elements of the pathological process that produce specific clinical problems.

Address: Unit of Critical Care, NHLI Division, Imperial College of Science, Technology & Medicine and Royal Brompton Hospital, London SW3 6NP, UK.

DOI: 10.1136/thorax.57.9.823

Link outs

Free resources

Full Text Sources:

Other Literature Sources:

https://www.lens.org/lens/search/patent/list?q=ref...

Subscription / membership required

Full Text Sources:

http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linko...

MeSH Terms: Administration, Inhalation, Adrenal Cortex Hormones, Antioxidants, Critical Care, Epoprostenol, Fluid Therapy, Humans, Lipoxygenase Inhibitors, Nitric Oxide, Phosphatidic Acids, Prostaglandins E, Synthetic, Pulmonary Surfactants, Randomized Controlled Trials as Topic, Respiratory Distress Syndrome, Thromboxane-A Synthase, Vasodilator Agents